BioSynTech Malaysia Group Sdn Bhd
199701004244 (419740-A)
No. 12A, Jalan TP 5,
Taman Perindustrian UEP,
47600 Subang Jaya,
Selangor, Malaysia
WhatsApp/Call: +6 016 216 0492
E : info@bstmgroup.com
MedChemExpress (MCE) offers a wide range of high quality research chemicals and biochemicals including novel bioactive compounds, dye reagents, peptides and natural compounds for laboratory and scientific use....
CT’s Neptune Block Blocking Buffer is non-mammalian and designed primarily for antigen-down ELISA formats as well as sandwich assays with high background problems....
Cell-cell adhesion is critical for cells and organisms to function, as it is the mechanism that keeps tissues and organs intact....
Directly conjugated antibodies are accurate and reliable research tools for a broad range of applications. Over 8,300 of the most popular antibodies are now also available as AC, HRP, PE, FITC, Alexa Fluor® 488, 546, 594, 647, 680, and 790 conjugates. ...
Each antibody is manufactured and validated on-site with a unique end-to-end control of the entire antibody life cycle...
Get Free Quote Now ...
CA77.1 (Prod. No. AG-CR1-0165) is a novel selective chaperone-mediated autophagy (CMA) activator by increasing the expression of the lysosomal receptor LAMP2A. CA77.1 is able to activate CMA in vitro and in vivo. It has been shown in animal studies that administration of CA77.1 may help...
Santa Cruz offers conjugated anti-mouse IgG binding proteins for use in WB, IF, IHC and FCM applications, representing a substantial improvement over conventional polyclonal secondary antibodies for these applications....
The ubiquilin protein family plays an important role in protein homeostasis via the ubiquitin-proteasome system. Research has linked ubiquilin function to neurodegenerative disorders like Alzheimer's disease, as well as some cancers....
Antibody specificity is of pivotal importance in clinical diagnosis, OriGene has developed UltraMAB™, a class of monoclonal antibodies of ultra specificity for such rigorous requirement. ...
